WHY INVEST IN THT 2026?
Build Connections & Elevate Your Brand
The Technology and Heart Failure Therapeutics® (THT®) conference will return March 2-4, 2026 in Boston! THT 2026® will provide an immersive platform to spotlight the next wave of advancements in device technologies, digital platforms, and combination therapies. Designed for a collaborative, multidisciplinary audience, THT® 2026 will deliver cutting-edge presentations, in-depth case discussions, and forward-thinking perspectives on regulatory developments—including live engagement with representatives from the FDA.
Why THT® 2026 Will Stand Out:
- Lead in Innovation: Join 1,500+ attendees—showcase your brand and connect with key decision-makers.
- Present the Future of Heart Failure Care: Share your latest breakthroughs through dynamic scientific sessions, technology showcases, and data-driven discussions.
- Expand Your Reach Through Strategic Networking: Take advantage of unmatched opportunities to connect with clinicians, investors, startups, and regulators across the industry.
Who’s Attending THT®?
Industry Opportunities Coming Soon!
The official THT® 2026 Industry Prospectus will be released in early September. This is your gateway to securing high-impact opportunities, including sponsorships, exhibits, and academic satellite programs.
Not on our mailing list? Be sure to complete the form below to receive the prospectus as soon as it’s available. You’ll be among the first to explore partnership options and receive timely updates.
Below is a preview of the opportunities that will be available!